Skin manifestations of SARS‐CoV‐2 Omicron variant: Clinical, pathological, and immunological insights.

This article presents a study on the skin manifestations of the SARS-CoV-2 Omicron variant. The study found that approximately 18.69% of patients diagnosed with COVID-19 during the Omicron wave experienced skin symptoms related to the Omicron variant. The researchers observed various types of rashes, including a novel papular urticarial-like rash. The study suggests that skin manifestations can vary depending on the specific viral strains involved, providing important information for clinical diagnosis. The researchers also found evidence of endothelial damage caused by the spike protein of SARS-CoV-2 in the skin of patients with Omicron-associated rashes. This study provides valuable insights into the diagnosis of Omicron-associated skin eruptions. [Extracted from the article]